News Releases

Date	Title and Summary	View
Nov 06, 2019	Janssen to Present Latest Research from Robust Blood Cancer and Cardiovascular Disease Portfolios at this Year’s American Society of Hematology Annual Meeting
Oct 31, 2019	Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen’s Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC
Oct 29, 2019	15 New Tests from the Same Bottle of Johnson’s Baby Powder Previously Tested by FDA Find No Asbestos
Oct 23, 2019	Auris Health Announces Late-Breaking Results from First-in-Human Study of Monarch™ Platform
Oct 23, 2019	Janssen Seeks to Expand Use of TREMFYA®▼ (guselkumab) in the Treatment of Adults with Active Psoriatic Arthritis
Oct 21, 2019	Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Oct 18, 2019	CHMP Grants Positive Opinion for Expanded Use of Janssen’s Darzalex®▼(daratumumab) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible
Oct 18, 2019	Johnson & Johnson Consumer Inc. To Voluntarily Recall A Single Lot Of Johnson's Baby Powder In The United States
Oct 18, 2019	Johnson & Johnson to Host Investor Conference Call on Voluntary Baby Powder Lot Recall
Oct 18, 2019	Janssen Receives Positive CHMP Opinion for SPRAVATO® (ESKETAMINE) Nasal Spray for Adults with Treatment Resistant Major Depressive Disorder